Great insights @Lucretious, thank you
Without delving too deeply into the science, the fundamental point when comparing other screening tests to Colostat is the cost/accuracy ratio. Obviously, mass population screening is only feasible with an inexpensive, simple, and appropriately accurate test. Additionally, patient compliance plus the involvement of health professionals' guidance following a positive result, are highly desirable.
I'm with you regarding a major deal! If I were Exact Sciences I'd pounce in it. However, I imagine they are inundated with companies trying to sell them their tech all the time, must be difficult to sort the woods from the trees... Maybe Exact will have representatives at the highly reputable upcoming ASCO Annual Meeting, where Rhythm will be presenting their research?
- Forums
- ASX - By Stock
- RHY
- TGA /FDA/EMA/MHRA
TGA /FDA/EMA/MHRA, page-13
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.2¢ |
Change
-0.002(3.13%) |
Mkt cap ! $15.41M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.2¢ | $9.837K | 157.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49398 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 29999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49398 | 0.062 |
1 | 133316 | 0.060 |
1 | 18000 | 0.056 |
2 | 19091 | 0.055 |
2 | 100000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 29999 | 1 |
0.067 | 260000 | 1 |
0.069 | 117678 | 1 |
0.070 | 1794 | 1 |
0.071 | 117305 | 2 |
Last trade - 13.01pm 26/08/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |